Follow the people · Insider
Gabriele M. Cerrone
Gabriele M. Cerrone files insider transactions with the SEC as an executive chairman of OKYO Pharma (OKYO). We hold 4 disclosed purchases and sales filed since 27 April 2022, 4 of them in the last 90 days.
- Files forOKYO
- Disclosed buys and sells4 in all, 4 in the last 90 days
- Last disclosure7 August 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 17 May 2022 — 21 July 2026Executive Chairman · OKYO Pharma (OKYO)11 Form 4 lines · source: SEC Form 4
- Filed 12 June 2026 — 21 July 2026Director and 10% owner · Tiziana Life Sciences (TLSA)4 Form 4 lines · source: SEC Form 4
- Filed 25 April 2022 — 13 June 2025Director and 10% owner · Accustem Sciences (ACUT)17 Form 4 lines · source: SEC Form 4
Everything they disclosed
32 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 15,000 shares of Tiziana Life SciencesSEC Form 47 August 2026COMMON STOCK · traded 12 June 2026 · filed 7 August 2026
- ▲ bought on the open market 42,357 shares of Tiziana Life SciencesSEC Form 47 August 2026COMMON STOCK · traded 21 July 2026 · filed 7 August 2026
- ▲ bought on the open market 22,500 shares of OKYO PharmaSEC Form 47 August 2026COMMON STOCK · traded 21 July 2026 · filed 7 August 2026
- ▲ bought on the open market 25,000 shares of OKYO PharmaSEC Form 47 August 2026COMMON STOCK · traded 20 July 2026 · filed 7 August 2026
- was granted 42,357 shares of Tiziana Life SciencesSEC Form 423 July 2026COMMON STOCK · traded 21 July 2026 · filed 23 July 2026
- was granted 22,500 shares of OKYO PharmaSEC Form 423 July 2026COMMON STOCK · traded 21 July 2026 · filed 23 July 2026
- was granted 25,000 shares of OKYO PharmaSEC Form 421 July 2026COMMON STOCK · traded 20 July 2026 · filed 21 July 2026
- was granted 15,000 shares of Tiziana Life SciencesSEC Form 417 June 2026COMMON STOCK · traded 12 June 2026 · filed 17 June 2026
- was granted 300,000 shares of OKYO PharmaSEC Form 410 June 2026COMMON STOCK · traded 8 June 2026 · filed 10 June 2026
- ▲ bought on the open market 2,000 shares of Accustem SciencesSEC Form 416 June 2025Common Stock · traded 13 June 2025 · filed 16 June 2025
- ▲ bought on the open market 400 shares of Accustem SciencesSEC Form 416 June 2025Common Stock · traded 13 June 2025 · filed 16 June 2025
- ▲ bought on the open market 28,205 shares of Accustem SciencesSEC Form 413 June 2025Common Stock · traded 11 June 2025 · filed 13 June 2025
- ▲ bought on the open market 8,991 shares of Accustem SciencesSEC Form 413 June 2025Common Stock · traded 12 June 2025 · filed 13 June 2025
- ▲ bought on the open market 35,000 shares of Accustem SciencesSEC Form 410 April 2025Common Stock · traded 8 April 2025 · filed 10 April 2025
- ▲ bought on the open market 3,000 shares of Accustem SciencesSEC Form 410 April 2025Common Stock · traded 9 April 2025 · filed 10 April 2025
- ▲ bought on the open market 100,000 shares of Accustem SciencesSEC Form 48 April 2025Common Stock · traded 18 March 2025 · filed 8 April 2025
- ▲ bought on the open market 17,802 shares of Accustem SciencesSEC Form 48 April 2025Common Stock · traded 7 April 2025 · filed 8 April 2025
- ▲ bought on the open market 35,000 shares of Accustem SciencesSEC Form 48 April 2025Common Stock · traded 7 April 2025 · filed 8 April 2025
- ▲ bought on the open market 100,000 shares of Accustem SciencesSEC Form 43 January 2025Common Stock · traded 31 December 2024 · filed 3 January 2025
- acquired or disposed of, other 499,468 shares of OKYO PharmaSEC Form 431 October 2023Ordinary Shares · traded 23 October 2023 · filed 31 October 2023
- acquired or disposed of, other 70,071 shares of OKYO PharmaSEC Form 431 October 2023Ordinary Shares · traded 27 October 2023 · filed 31 October 2023
- ▲ bought on the open market 5,000 shares of Accustem SciencesSEC Form 43 January 2023Common Stock · traded 30 December 2022 · filed 3 January 2023
- ▲ bought on the open market 3,729 shares of Accustem SciencesSEC Form 45 December 2022Common Stock · traded 2 December 2022 · filed 5 December 2022
- ▲ bought on the open market 24,500 shares of Accustem SciencesSEC Form 422 November 2022Common Stock · traded 18 November 2022 · filed 22 November 2022
- ▲ bought on the open market 10,000 shares of Accustem SciencesSEC Form 42 August 2022Common Stock · traded 1 August 2022 · filed 2 August 2022
- ▲ bought on the open market 20,000 shares of Accustem SciencesSEC Form 49 June 2022Common Stock · traded 8 June 2022 · filed 9 June 2022
- ▲ bought on the open market 5,800,000 shares of OKYO PharmaSEC Form 420 May 2022Ordinary Shares · traded 19 May 2022 · filed 20 May 2022
- ▲ bought on the open market 37,500 shares of OKYO PharmaSEC Form 419 May 2022American Depositary Shares · traded 19 May 2022 · filed 19 May 2022
- ▲ bought on the open market 1,625,000 shares of OKYO PharmaSEC Form 418 May 2022Ordinary Shares · traded 17 May 2022 · filed 18 May 2022
- ▲ bought on the open market 25,000 shares of OKYO PharmaSEC Form 418 May 2022American Depositary Shares · traded 17 May 2022 · filed 18 May 2022
- ▲ bought on the open market 4,181 shares of Accustem SciencesSEC Form 427 April 2022Common Stock · traded 25 April 2022 · filed 27 April 2022
- ▲ bought on the open market 5,266 shares of Accustem SciencesSEC Form 427 April 2022Common Stock · traded 26 April 2022 · filed 27 April 2022
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.